A. MacGowan

发表

Effect of Physical Activity on Age-Related Changes in Cardiac Function and Performance in Women. Circulation: Cardiovascular Imaging 2015, 8, e002086

Andrew M Blamire, Roy Taylor, Djordje G. Jakovljevic, 2016 .

The global threat of antimicrobial resistance: science for intervention

F. Baquero, J. Rolain, B. Sigaúque, 2015, New microbes and new infections.

Impact of rapid microbial identification on clinical outcomes in bloodstream infection: the RAPIDO randomised trial.

A. MacGowan, M. Wilcox, K. Pike, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net

Leonhard Held, Stephan Harbarth, Stavros Nikolakopoulos, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

H. Goossens, M. Bonten, H. Jafri, 2016, The Journal of antimicrobial chemotherapy.

Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography.

A. MacGowan, J. Sunderland, C. Tobin, 2001, The Journal of antimicrobial chemotherapy.

Clinical diagnosis and treatment of common respiratory tract infections in relation to microbiological profiles in rural health facilities in China: implications for antibiotic stewardship

K. Bowker, A. MacGowan, Ya-ping Pan, 2021, BMC Family Practice.

Pathways to optimising antibiotic use in rural China: identifying key determinants in community and clinical settings, a mixed methods study protocol

K. Bowker, A. MacGowan, M. Hickman, 2019, BMJ Open.

Surveillance of antimicrobial resistance

D. Livermore, A. MacGowan, M. Wale, 1998, BMJ.

Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection.

K. Bowker, A. MacGowan, W. Alfouzan, 2017, International journal of antimicrobial agents.

The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee.

N Woodford, G Kahlmeter, F M Aarestrup, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia

A. MacGowan, Mbiye Mpenge, A. Macgowan, 2015, Therapeutics and clinical risk management.

Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents

D. Marriott, D. Paterson, A. MacGowan, 2020, Clinical Pharmacokinetics.

Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints.

K. Bowker, A. MacGowan, J. Sunderland, 1998, The Journal of antimicrobial chemotherapy.

Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial Chemotherapy.

A. MacGowan, R. Howe, M. Wootton, 2017, The Journal of antimicrobial chemotherapy.

Nucleotide and Amino Acid Sequences of the Metallo-β-Lactamase, ImiS, from Aeromonas veronii bv. sobria

A. MacGowan, P. Bennett, D. Payne, 1998, Antimicrobial Agents and Chemotherapy.

Endophthalmitis at the Bristol Eye Hospital: an 11-year review of 47 patients.

A. MacGowan, I. Hassan, S. Cook, 1992, The Journal of hospital infection.

Expression of tcaA and mprF and glycopeptide resistance in clinical glycopeptide-intermediate Staphylococcus aureus (GISA) and heteroGISA strains.

A. MacGowan, M. Wootton, T. Walsh, 2005, Biochimica et biophysica acta.

Role of pharmacokinetics and pharmacodynamics: does the dose matter?

A. MacGowan, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vitro models, in vivo models, and pharmacokinetics: what can we learn from in vitro models?

K. Bowker, A. MacGowan, C. Rogers, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1

G. Drusano, A. MacGowan, W. Hope, 2015, Antimicrobial Agents and Chemotherapy.

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

A. MacGowan, P. Bennett, R. Howe, 2001, The Journal of antimicrobial chemotherapy.

Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome.

A. MacGowan, L. White, V. Reed, 2000, The Journal of antimicrobial chemotherapy.

External quality assessment of the serum bactericidal test: results of a methodology/interpretation questionnaire.

K. Bowker, A. MacGowan, L. White, 1997, The Journal of antimicrobial chemotherapy.

Abstracts from the NIHR INVOLVE Conference 2017

Michael Nunns, Sara Schroter, Jenny Donovan, 2017, Research Involvement and Engagement.

A critical assessment of the agar dilution chequerboard technique for studying in-vitro antimicrobial interactions using a representative beta-lactam, aminoglycoside and fluoroquinolone.

K. Bowker, A. MacGowan, M. Wootton, 1995, The Journal of antimicrobial chemotherapy.

Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans.

K. Bowker, A. MacGowan, D. Reeves, 1998, Journal of Antimicrobial Chemotherapy.

Pharmacodynamics of linezolid in a clinical isolate of Streptococcus pneumoniae genetically modified to express lux genes.

R. Lewis, A. MacGowan, V. Salisbury, 2003, Journal of Antimicrobial Chemotherapy.

Extent, quality and impact of patient and public involvement in antimicrobial drug development research: A systematic review

A. MacGowan, E. Bird, S. Grier, 2017, Health expectations : an international journal of public participation in health care and health policy.

Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING)

L. Leibovici, A. MacGowan, I. Wiegand, 2016, BMJ Open.

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.

A. MacGowan, M. Steinbakk, A. Rodloff, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance Programme.

A. MacGowan, R. Reynolds, D. Felmingham, 2003, The Journal of antimicrobial chemotherapy.

A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection.

H. Humphreys, S. Willatts, A. MacGowan, 1992, The Journal of antimicrobial chemotherapy.

Current Antibiotic Treatment and Outcome for Lower Respiratory Tract Infections

A. MacGowan, A. Lovering, T. Halladay, 1998 .

Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?

C. Mcnulty, A. Charlett, A. MacGowan, 2011, The Journal of antimicrobial chemotherapy.

The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.

A. Gray, P. Fenn, A. MacGowan, 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement.

G. Bannister, A. Blom, A. MacGowan, 2011, The Journal of antimicrobial chemotherapy.

Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: Findings from a Mendelian randomisation study

N. Timpson, A. Hingorani, J. Baillie, 2022, medRxiv.

A non-fatal case of hantavirus cardiopulmonary syndrome imported into the UK (ex Panama), July 2014

A. MacGowan, R. Hewson, S. Lumley, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial.

A. MacGowan, A. Macgowan, 1999, Expert opinion on investigational drugs.

Strain-Specific Expression Levels of pbp4 Exist in Isolates of Glycopeptide-Intermediate Staphylococcus aureus (GISA) and Heterogeneous GISA

A. MacGowan, P. Bennett, M. Wootton, 2005, Antimicrobial Agents and Chemotherapy.

Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07.

D. Livermore, A. MacGowan, M. Ellington, 2012, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.

A. MacGowan, K. Agwuh, Kenneth N Agwuh, 2006, The Journal of antimicrobial chemotherapy.

Microneedle biosensors for real-time, minimally invasive drug monitoring of phenoxymethylpenicillin: a first-in-human evaluation in healthy volunteers.

P. Georgiou, A. MacGowan, D. O'Hare, 2019, The Lancet. Digital health.

Finding and engaging patients and the public to work collaboratively on an acute infection microbiology research public panel

A. MacGowan, S. Grier, M. Stoddart, 2018, Research Involvement and Engagement.

Antimicrobial therapy: principles of use

A. MacGowan, E. Macnaughton, 2013, Medicine.

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.

A. MacGowan, I. Odenholt, M. Steinbakk, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci.

K. Bowker, A. MacGowan, M. Wootton, 1999, The Journal of antimicrobial chemotherapy.

Epidemiology and resource utilization for patients hospitalized for lower respiratory tract infection.

A. MacGowan, D. Irwin, P. Anderson, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis.

K. Bowker, A. MacGowan, J. Harvey, 2000, The Journal of antimicrobial chemotherapy.

Challenges and opportunities for involving patients and the public in acute antimicrobial medicine development research: an interview study

A. MacGowan, S. Grier, A. Gibson, 2019, BMJ Open.

Gastric pH and colonisation in sucralfate treated patients

S. Willatts, A. MacGowan, D. Speller, 2004, Intensive Care Medicine.

Activities of Moxifloxacin against, and Emergence of Resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, C. Rogers, 2003, Antimicrobial Agents and Chemotherapy.

Corrigendum to “The global threat of antimicrobial resistance: science for intervention” [New Microbes New Infect 6 (2015): 22–29]

F. Baquero, J. Rolain, J. Carlet, 2015, New microbes and new infections.

Doxycycline in UK guidelines for hospital-acquired pneumonia: where is the evidence base?

D. Livermore, A. MacGowan, C. Horner, 2018, The Journal of antimicrobial chemotherapy.

Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria.

K. Bowker, A. MacGowan, M. Wootton, 1997, The Journal of antimicrobial chemotherapy.

Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea.

A. MacGowan, A. Lovering, D. Reeves, 1997, The Journal of antimicrobial chemotherapy.

Heterogeneous resistance to vancomycin in Staphylococcus aureus.

A. MacGowan, P. Bennett, R. Howe, 2000, The Journal of antimicrobial chemotherapy.

Prevalence of antibiotic resistance in Escherichia coli isolated from urine samples routinely referred by general practitioners in a large urban centre in south-west England.

C. Mcnulty, K. Bowker, A. MacGowan, 2015, The Journal of antimicrobial chemotherapy.

A Multicenter Study Evaluating the Current Strategies for Isolating Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides

A. MacGowan, R. Howe, M. Wootton, 2006, Journal of Clinical Microbiology.

Listeria monocytogenes and its role in human infection.

A. MacGowan, R. Lamont, R. Postlethwaite, 1988, The Journal of infection.

Time-to-positivity in bloodstream infection is not a prognostic marker for mortality: analysis of a prospective multicentre randomised control trial.

P. Ghazal, A. MacGowan, F. Hamilton, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Genetic basis of tetracycline resistance in clinical isolates of Listeria monocytogenes

A. MacGowan, J. McLauchlin, P. Trieu-Cuot, 1992, Antimicrobial Agents and Chemotherapy.

The pharmacodynamics of fosfomycin against Staphylococcus aureus studied in an in vitro model of infection.

K. Bowker, A. MacGowan, A. Noel, 2020, International journal of antimicrobial agents.

An in vitro biofilm model of Staphylococcus aureus infection of bone

K. Bowker, A. MacGowan, S. Nelson, 2019, Letters in applied microbiology.

The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against &bgr;-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection

K. Bowker, A. MacGowan, A. Noel, 2016, The Journal of antimicrobial chemotherapy.

Comparative antibacterial effects of moxifloxacin and levofloxacin on Streptococcus pneumoniae strains with defined mechanisms of resistance: impact of bacterial inoculum.

K. Bowker, A. MacGowan, A. Noel, 2013, The Journal of antimicrobial chemotherapy.

Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.

K. Bowker, A. MacGowan, A. Noel, 2009, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of Ceftazidime plus the Serine β-Lactamase Inhibitor AM-112 against Escherichia coli Containing TEM-1 and CTX-M-1 β-Lactamases

K. Bowker, A. MacGowan, C. Rogers, 2004, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Ceftazidime plus the Serine (cid:2) -Lactamase Inhibitor AM-112 against Escherichia coli Containing TEM-1 and CTX-M-1 (cid:2) -Lactamases

K. Bowker, A. MacGowan, C. Rogers, 2004 .

In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and heteroVRSA (hVRSA).

A. MacGowan, P. Bennett, R. Howe, 2002, The Journal of antimicrobial chemotherapy.

Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study.

A. Oliver, L. Leibovici, D. Paterson, 2019, International journal of antimicrobial agents.

Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.

A. MacGowan, Derek F. J. Brown, 2010, The Journal of antimicrobial chemotherapy.

CLOSTRIDIA AND NEUTROPENIC ENTEROCOLITIS

M. Potter, A. MacGowan, R. Slade, 1988, The Lancet.

Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains.

A. MacGowan, P. Bennett, M. Wootton, 2005, The Journal of antimicrobial chemotherapy.

Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus.

A. MacGowan, P. Bennett, R. Howe, 1999, The Journal of antimicrobial chemotherapy.

Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models.

K. Bowker, A. MacGowan, A. Macgowan, 2002, International journal of antimicrobial agents.

Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper.

J. Turnidge, A. MacGowan, G. Kahlmeter, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prophylactic oral fluconazole and candida fungaemia

A. MacGowan, D. Reeves, D. Felmingham, 1991, The Lancet.

Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species

A. MacGowan, V. Cattoir, F. Guérin, 2022, Antimicrobial agents and chemotherapy.

Human peritoneal macrophage phagocytic, killing, and chemiluminescent responses to opsonized Listeria monocytogenes

W. Keane, A. MacGowan, P. Peterson, 1983, Infection and immunity.

Virulence of Listeria spp.: course of infection in resistant and susceptible mice.

A. MacGowan, T. Mainou-fowler, R. Postlethwaite, 1988, Journal of medical microbiology.

Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides.

A. MacGowan, A. Macgowan, 1998, Therapeutic drug monitoring.

Original articles Distribution and expression of -lactamase genes among Aeromonas spp.

A. MacGowan, P. Bennett, T. Walsh, 1997 .

A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible beta-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity.

A. MacGowan, P. Bennett, D. Payne, 1995, The Journal of antimicrobial chemotherapy.

The pharmacokinetics of once daily gentamicin in neutropenic adults with haematological malignancy.

A. MacGowan, N. Brown, L. White, 1994, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of Telavancin Studied in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. MacGowan, A. Noel, 2010, Antimicrobial Agents and Chemotherapy.

Future treatment options for Gram-positive infections--looking ahead.

A. MacGowan, E. Barton, A. Macgowan, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for antibiotic Assays meeting for participants, October 1993.

A. MacGowan, D. Reeves, D. Warnock, 1995, The Journal of antimicrobial chemotherapy.

Assay of low trough serum gentamicin concentrations by fluorescence polarization immunoassay.

A. MacGowan, D. Reeves, A. Lovering, 1994, Journal of Antimicrobial Chemotherapy.

Serum monitoring and practicalities of once-daily aminoglycoside dosing.

A. MacGowan, D. Reeves, 1994, The Journal of antimicrobial chemotherapy.

Development, validation and application of a novel HPLC‐MS/MS method for the measurement of minocycline in human plasma and urine

A. MacGowan, S. Grier, M. Bayliss, 2019, Journal of pharmaceutical and biomedical analysis.

A simple high performance liquid chromatography (HPLC) assay for aciclovir and ganciclovir in serum.

A. MacGowan, J. Sunderland, D. Reeves, 1996, The Journal of antimicrobial chemotherapy.

Control of varicella-zoster infection on renal and other specialist units.

A. MacGowan, C. Perry, E. Caul, 1997, The Journal of hospital infection.

The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments.

K. Bowker, A. MacGowan, A. Noel, 2015, International Journal of Antimicrobial Agents.

Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae

K. Bowker, A. MacGowan, A. Noel, 2012, Antimicrobial Agents and Chemotherapy.

A high performance liquid chromatography (HPLC) assay for linezolid in continuous ambulatory peritoneal dialysis fluid (CAPDF).

A. MacGowan, J. Sunderland, A. Lovering, 2003, The Journal of antimicrobial chemotherapy.

In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patients.

K. Bowker, A. MacGowan, M. Wootton, 2002, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of Once-a-Day Netilmicin (4.5 mg/kg) in Neonates

A. MacGowan, J. J. Dixon, A. Leaf, 2001, Journal of chemotherapy.

DUTY study protocol

William Hollingworth, Jonathan A C Sterne, Kerenza Hood, 2016 .

The elution and binding characteristics of rifampicin for three commercially available protein-sealed vascular grafts.

A. MacGowan, D. Reeves, A. Lovering, 1996, The Journal of antimicrobial chemotherapy.

Why monitor peak vancomycin concentrations?

M. Wysocki, A. MacGowan, B. Oppenheim, 1995, The Lancet.

The pharmacokinetics of meropenem in surgical patients with moderate or severe infections.

A. MacGowan, D. Reeves, D. Leaper, 1995, The Journal of antimicrobial chemotherapy.

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.

A. MacGowan, A. Macgowan, 2003, The Journal of antimicrobial chemotherapy.

Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory.

K. Bowker, A. MacGowan, J. Sunderland, 2006, International journal of antimicrobial agents.

Antibiotic treatment of gram-positive bone and joint infections.

A. MacGowan, E. Darley, A. Macgowan, 2004, The Journal of antimicrobial chemotherapy.

A comparison of the penetration of cefuroxime and cephamandole into bone, fat and haematoma fluid in patients undergoing total hip replacement.

G. Bannister, K. Bowker, A. MacGowan, 1997, The Journal of antimicrobial chemotherapy.

Importance of air quality and related factors in the prevention of infection in orthopaedic implant surgery.

A P MacGowan, G C Bannister, G. Bannister, 1998, The Journal of hospital infection.

Unique Aspects of Content Unique Aspects of Software

A. MacGowan, A. Macgowan, 2010 .

Pharmacokinetics of FCE 22101 in man following different modes of administration.

A. MacGowan, D. Reeves, A. Lovering, 1989, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of dalbavancin studied in an in vitro pharmacokinetic system.

K. Bowker, A. MacGowan, A. Noel, 2006, The Journal of antimicrobial chemotherapy.

Development of the quinolones.

A. MacGowan, Alasdair P MacGowan, Monique I Andersson, 2003, The Journal of antimicrobial chemotherapy.

Prediction of Fluoroquinolone Susceptibility Directly from Whole-Genome Sequence Data by Using Liquid Chromatography-Tandem Mass Spectrometry To Identify Mutant Genotypes

K. Bowker, A. MacGowan, K. Heesom, 2017, Antimicrobial Agents and Chemotherapy.

Bacterial Strain-to-Strain Variation in Pharmacodynamic Index Magnitude, a Hitherto Unconsidered Factor in Establishing Antibiotic Clinical Breakpoints

K. Bowker, A. MacGowan, R. Reynolds, 2009, Antimicrobial Agents and Chemotherapy.

Antibacterial Effects of Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae Strains for Which MICs Are High, in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, C. Rogers, 2004, Antimicrobial Agents and Chemotherapy.

Mechanism of Fluoroquinolone Resistance Is an Important Factor in Determining the Antimicrobial Effect of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, A. Macgowan, 2003, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Gemifloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. MacGowan, C. Rogers, 2001, Antimicrobial Agents and Chemotherapy.

Activity of Moxifloxacin, Administered Once a Day, against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model of Infection

K. Bowker, A. MacGowan, M. Wootton, 1999, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Minocycline against Staphylococcus aureus in an In Vitro Pharmacokinetic Model

Alasdair P. MacGowan, K. Bowker, A. MacGowan, 2008, Antimicrobial Agents and Chemotherapy.

The Diagnosis of Urinary Tract infection in Young children (DUTY): a diagnostic prospective observational study to derive and validate a clinical algorithm for the diagnosis of urinary tract infection in children presenting to primary care with an acute illness.

J. Sterne, P. Whiting, M. Lawton, 2016, Health technology assessment.

Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests.

A. MacGowan, R. Wise, A. Macgowan, 2001, The Journal of antimicrobial chemotherapy.

Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.

A. MacGowan, M. Struelens, M. Steinbakk, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone.

K. Bowker, A. MacGowan, M. Wootton, 1996, The Journal of antimicrobial chemotherapy.

EUCAST expert rules in antimicrobial susceptibility testing.

A P MacGowan, G Kahlmeter, P. Nordmann, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer Study

A. MacGowan, M. Gilchrist, T. Rawson, 2021, Open Forum Infectious Diseases.

Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA.

A. MacGowan, P. Bennett, R. Howe, 2004, The Journal of antimicrobial chemotherapy.

EUCAST technical note on tigecycline.

A. MacGowan, I. Odenholt, M. Steinbakk, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Pharmacodynamics of Ceftaroline against Staphylococcus aureus Studied in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. MacGowan, A. Noel, 2013, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of the Antibacterial Effect of and Emergence of Resistance to Doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, A. Noel, 2012, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of Razupenem (PZ601) Studied in an In Vitro Pharmacokinetic Model of Infection

K. Bowker, A. MacGowan, A. Noel, 2011, Antimicrobial Agents and Chemotherapy.

A review of the pharmacokinetics and pharmacodynamics of aztreonam.

C. Ramsey, A. MacGowan, A. Macgowan, 2016, The Journal of antimicrobial chemotherapy.

Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia

K. Bowker, A. MacGowan, A. Macgowan, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.

Stephan Harbarth, Johan W Mouton, John Turnidge, 2011, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

An open study of the efficacy and safety of single dose fosfomycin trometamol in treatment of hospitalised patients with urinary tract infection (pilot study)

R. A. Bailey, A. MacGowan, D. Reeves, 2005, Infection.

European Congress of Clinical Microbiology and Infectious Disease

A. MacGowan, R. Howe, M. Wootton, 2004 .

Comparison of microbiological diagnosis of urinary tract infection in young children by routine health service laboratories and a research laboratory: Diagnostic cohort study

J. Sterne, P. Whiting, M. Lawton, 2017, PloS one.

Ampicillin-aminoglycoside interaction studies using Listeria monocytogenes.

K. Bowker, A. MacGowan, M. Wootton, 1998, The Journal of antimicrobial chemotherapy.

Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement.

G. Bannister, A. MacGowan, G. Narendra, 2002, The Journal of antimicrobial chemotherapy.

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria.

Johan W Mouton, Martin Steinbakk, A. MacGowan, 2003, The Journal of antimicrobial chemotherapy.

Continuous Infusion of β-Lactam Antibiotics

K. Bowker, A. MacGowan, Karen E. Bowker, 1998 .

Trade-Offs between Antibacterial Resistance and Fitness Cost in the Production of Metallo-β-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting

A. MacGowan, K. Heesom, M. Avison, 2021, Antimicrobial agents and chemotherapy.

A. MacGowan, K. Heesom, M. Avison, 2020, bioRxiv.

Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.

D. Livermore, A. MacGowan, R. Reynolds, 2004, The Journal of antimicrobial chemotherapy.

Identification and characterisation of Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates with atypical β-lactam susceptibility profiles using Orbitrap liquid chromatography-tandem mass spectrometry

A. MacGowan, K. Heesom, M. Avison, 2022, bioRxiv.

Heterogeneity at the beta-lactamase structural gene ampC amongst Citrobacter spp. assessed by polymerase chain reaction analysis: potential for typing at a molecular level.

A. MacGowan, P. Bennett, M. Avison, 1994, Journal of medical microbiology.

The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens.

K. Bowker, A. MacGowan, C. Rogers, 2000, The Journal of antimicrobial chemotherapy.

Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacin.

K. Bowker, A. MacGowan, C. Rogers, 2000, The Journal of antimicrobial chemotherapy.

Comparison of in-vitro pharmacodynamics of once and twice daily ciprofloxacin.

K. Bowker, A. MacGowan, C. Rogers, 1999, The Journal of antimicrobial chemotherapy.

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2

G. Drusano, A. MacGowan, W. Hope, 2015, Antimicrobial Agents and Chemotherapy.

Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study

L. Leibovici, A. MacGowan, I. Wiegand, 2018, BMJ Open.

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.

M. Singer, L. Aarons, A. MacGowan, 2005, The Journal of antimicrobial chemotherapy.

A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum.

A. MacGowan, J. Sunderland, L. White, 2001, The Journal of antimicrobial chemotherapy.

An isocratic high performance liquid chromatography (HPLC) assay for moxifloxacin, a new 8-methoxyquinolone.

A. MacGowan, J. Sunderland, C. Tobin, 1998, Journal of Antimicrobial Chemotherapy.

The antibacterial efficacy of levofloxacin and ciprofloxacin against Pseudomonas aeruginosa assessed by combining antibiotic exposure and bacterial susceptibility.

A. MacGowan, M. Wootton, H. Holt, 1999, The Journal of antimicrobial chemotherapy.

Distribution and expression of beta-lactamase genes among Aeromonas spp.

A. MacGowan, P. Bennett, T. Walsh, 1997, The Journal of antimicrobial chemotherapy.

Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: temporal changes correlated with frequent loss and gain events

J. Parkhill, S. Harris, A. MacGowan, 2017, BMC Genomics.

A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces.

A. MacGowan, J. Sunderland, A. Lovering, 2004, International journal of antimicrobial agents.

Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net.

A. MacGowan, D. Reeves, L. White, 1997, The Journal of antimicrobial chemotherapy.

Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to Glycopeptides

A. MacGowan, A. Bolmström, R. Howe, 2001, Journal of Clinical Microbiology.

Comparative Bactericidal Activities of Daptomycin and Vancomycin against Glycopeptide-Intermediate Staphylococcus aureus (GISA) and Heterogeneous GISA Isolates

A. MacGowan, M. Wootton, T. Walsh, 2006, Antimicrobial Agents and Chemotherapy.

The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model.

K. Bowker, A. MacGowan, P. Bennett, 2001, The Journal of antimicrobial chemotherapy.

Development, evaluation and application of an isocratic high-performance liquid chromatography (HPLC) assay for the simultaneous determination of aciclovir and its metabolite 9-carboxymethoxymethylguanine in human serum and cerebrospinal fluid.

A. MacGowan, A. Lovering, J. Darville, 2007, International journal of antimicrobial agents.

Viral infections in pregnancy: advice for healthcare workers.

A. MacGowan, M. Donati, S. K. Jacobson, 2014, The Journal of hospital infection.

Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review.

J. Higgins, G. Drusano, A. MacGowan, 2020, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of plazomicin and a comparator aminoglycoside, amikacin, studied in an in vitro pharmacokinetic model of infection.

K. Bowker, A. MacGowan, K. Krause, 2019, International journal of antimicrobial agents.

The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure.

A. MacGowan, D. Reeves, L. White, 1988, The Journal of antimicrobial chemotherapy.

The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone.

G. Bannister, A. MacGowan, T. Walsh, 2001, The Journal of antimicrobial chemotherapy.

Ofloxacin Photodegradation Products Possess Antimicrobial Activity

A. MacGowan, J. Sunderland, C. Tobin, 1999, Drugs.

Report from the EUCAST Subcommittee on the Role of Whole Genome Sequencing ( WGS ) in Antimicrobial Susceptibility Testing of Bacteria . Version 1 , 2016

F. Aarestrup, M. Mulvey, H. Hasman, 2016 .

Comparative evaluation of eight different in vitro pharmacodynamic models of infection. Activity of moxifloxacin against Escherichia coli and Streptococcus pneumoniae as an exemplary example.

K. Bowker, A. MacGowan, A. Dalhoff, 2019, International journal of antimicrobial agents.

Modifiable healthcare factors affecting 28-day survival in bloodstream infection: a prospective cohort study

A. MacGowan, M. Wilcox, K. Pike, 2020, BMC Infectious Diseases.

Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections

C. Tebé, L. Leibovici, A. MacGowan, 2018, Antimicrobial Resistance & Infection Control.

The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.

K. Bowker, A. MacGowan, A. Noel, 2021, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of aztreonam against Escherichia coli and Klebsiella oxytoca: defining pharmacodynamic targets.

K. Bowker, A. MacGowan, A. Noel, 2019, The Journal of antimicrobial chemotherapy.

Risk Factors for Treatment Failure and Mortality Among Hospitalized Patients With Complicated Urinary Tract Infection: A Multicenter Retrospective Cohort Study (RESCUING Study Group)

L. Leibovici, Y. Carmeli, C. Mussini, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The relationship between minimum inhibitory concentration and 28 day mortality in patients with a Gram-negative bloodstream infection: an analysis of data from a cohort study (BSI-FOO)

A. MacGowan, C. Rogers, Rebecca N. Evans, 2022, JAC-antimicrobial resistance.

ONTOGENY OF SUPEROXIDE ANION RELEASE BY MACROPHAGES IN NORMAL AND PLASMODIUM BERGHEI-INFECTED RATS

A. MacGowan, J. B. Solomon, 1981 .

Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia

A P MacGowan, P M Bennett, A. MacGowan, 1997, Antimicrobial agents and chemotherapy.

Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia

Timothy R. Walsh, Peter M. Bennett, Alasdair P. MacGowan, 1994 .

Sequence analysis of the L1 metallo-beta-lactamase from Xanthomonas maltophilia.

L. Hall, A. MacGowan, S. Assinder, 1994, Biochimica et biophysica acta.

A comparative study of the rifampicin binding and elution characteristics for collagen- and albumin-sealed vascular grafts.

A. MacGowan, A. Lovering, A. Macgowan, 1999, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

The use and therapeutic drug monitoring of teicoplanin in the UK.

A. MacGowan, E. Darley, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcome

A. MacGowan, D. Reeves, I. Harding, 1996, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Analyses of teicoplanin concentrations from 1994 to 2006 from a UK assay service.

A. MacGowan, A. Lovering, E. Sweeney, 2010, The Journal of antimicrobial chemotherapy.

Serum monitoring of teicoplanin.

A. MacGowan, D. Reeves, L. White, 1992, The Journal of antimicrobial chemotherapy.

The quality of clinical serum teicoplanin assays: an experimental European EQA distribution.

A. MacGowan, D. Reeves, L. White, 1996, The Journal of antimicrobial chemotherapy.

Concentration controlled and concentration defined clinical trials: do they offer any advantages for antimicrobial chemotherapy?

A. MacGowan, 1996, The Journal of antimicrobial chemotherapy.

The serum concentrations of desmethyl ofloxacin and ofloxacin N-oxide in seriously ill patients and their possible contributions to the antibacterial activity of ofloxacin.

K. Bowker, A. MacGowan, D. Reeves, 1994, The Journal of antimicrobial chemotherapy.

The pharmacokinetics of lomefloxacin in elderly patients with urinary tract infection following daily dosing with 400 mg.

A. MacGowan, D. Reeves, A. Lovering, 1991, The Journal of antimicrobial chemotherapy.

Interactions between Methicillin and Vancomycin in Methicillin-Resistant Staphylococcus aureus Strains Displaying Different Phenotypes of Vancomycin Susceptibility

A. MacGowan, P. Bennett, R. Howe, 1999, Journal of Clinical Microbiology.

Sequential antimicrobial therapy: pharmacokinetic and pharmacodynamic considerations in sequential therapy.

K. Bowker, A. MacGowan, 1998, The Journal of infection.

Clothing in laminar-flow operating theatres.

G. Bannister, K. Bowker, A. MacGowan, 1996, The Journal of hospital infection.

A long history of β-lactams for MRSA

A. MacGowan, F. Hamilton, 2019, Nature Microbiology.

A prospective, randomised trial of prophylactic antibiotics versus bag extraction in the prophylaxis of wound infection in laparoscopic cholecystectomy.

A. MacGowan, C. Perry, N. Moorjani, 2000, Annals of the Royal College of Surgeons of England.

The Rational Choice of Antimicrobials in Life-threatening Infections on Intensive Care Units

A. MacGowan, 1991 .

Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region

K. Bowker, A. MacGowan, K. Reyher, 2021, bioRxiv.

Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study

N. Maskell, A. MacGowan, A. Noel, 2021, Emergency Medicine Journal.

Comment on: Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.

K. Bowker, A. MacGowan, A. Noel, 2020, Journal of Antimicrobial Chemotherapy.

The activity of piperacillin/tazobactam against clinical isolates collected in 20 UK centres and the design of a disc test for susceptibility testing.

A. MacGowan, D. Reeves, H. Holt, 1993, The Journal of antimicrobial chemotherapy.

Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.

A. MacGowan, A. Macgowan, 2008, Clinical Microbiology and Infection.

Extended Spectrum β Lactamase (ESBL) producing bacteria in a large UK NHS Hospital Trust

A. MacGowan, A. Lovering, E. Darley, 2007 .

The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data.

C. Mcnulty, A. Montgomery, A. MacGowan, 2005, The Journal of antimicrobial chemotherapy.

Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review.

A. MacGowan, N. Brown, A. Thomson, 2016, The Journal of antimicrobial chemotherapy.

Antibacterial effect of imipenem/relebactam on aerobic Gram-negative bacilli: in vitro simulations of 7 or 14 day human exposures.

K. Bowker, A. MacGowan, A. Noel, 2019, The Journal of antimicrobial chemotherapy.

Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection

K. Bowker, A. MacGowan, A. Noel, 2018, The Journal of antimicrobial chemotherapy.

Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort study

L. Leibovici, A. MacGowan, I. Wiegand, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Blood parameters measured on admission as predictors of outcome for COVID-19; a prospective UK cohort study

N. Maskell, K. Elvers, A. MacGowan, 2020, medRxiv.

Monitoring treatment with aminoglycoside antibiotics.

A. MacGowan, D. Reeves, 1993, BMJ.

Elements of design: the knowledge on which we build.

A. MacGowan, A. Macgowan, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical implications of antimicrobial resistance for therapy.

A. MacGowan, A. Macgowan, 2008, The Journal of antimicrobial chemotherapy.

Resistance determinants in strains of Clostridium difficile from two geographically distinct populations.

A. MacGowan, P. Bennett, M. Avison, 2004, International journal of antimicrobial agents.

Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam.

S. Brewster, A. MacGowan, J. Gingell, 1995, British journal of urology.

Clostridium difficile-associated diarrhoea and length of hospital stay

A. MacGowan, A. Lovering, C. Redpath, 1995 .

Sequence analysis of two chromosomally mediated inducible beta-lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinase.

L. Hall, A. MacGowan, P. Bennett, 1995, The Journal of antimicrobial chemotherapy.

An eight-year survey of the antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in a district general hospital and the local community.

A. MacGowan, N. Brown, D. Reeves, 1993, The Journal of antimicrobial chemotherapy.

Detection of extended-spectrum beta-lactamases with Etest and double-disc potentiation methods.

A. King, A. MacGowan, J. Andrews, 2000, The Journal of antimicrobial chemotherapy.

Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.

A. Oliver, L. Leibovici, D. Paterson, 2021, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of Moxifloxacin against Anaerobes Studied in an In Vitro Pharmacokinetic Model

K. Bowker, A. MacGowan, A. Noel, 2005, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever

N. M. Dung, Le Huu Nhat Minh, H. T. Loan, 1996, Antimicrobial agents and chemotherapy.

Determination by HPLC of chlortetracycline in pig faeces.

A. MacGowan, J. Sunderland, A. Lovering, 2003, The Journal of antimicrobial chemotherapy.

Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study

L. Leibovici, A. MacGowan, I. Wiegand, 2018, Infection and drug resistance.

Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study

C. Tebé, L. Leibovici, A. MacGowan, 2019, Antimicrobial resistance and infection control.

Prediction of cephalosporin and carbapenem susceptibility in multi-drug resistant Gram-negative bacteria using liquid chromatography-tandem mass spectrometry

A. MacGowan, K. Heesom, M. Avison, 2017, bioRxiv.

The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction

P. Abrams, A. MacGowan, C. Tomson, 2017, Neurourology and urodynamics.

Chronic SARS-CoV-2 infection and viral evolution in a hypogammaglobulinaemic individual.

N. Maskell, A. MacGowan, D. Matthews, 2021, medRxiv.

Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.

I. Morrissey, P. Nordmann, A. MacGowan, 2013, The Journal of antimicrobial chemotherapy.

Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility

G. Lina, J. Turnidge, A. MacGowan, 2020, Clinical Microbiology and Infection.

Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.

A. MacGowan, R. Reynolds, D. Felmingham, 2003, The Journal of antimicrobial chemotherapy.

ANTIBIOTICS IN THE PROPHYLAXIS OF WOUND INFECTION IN LAPAROSCOPIC CHOLECYSTECTOMY

A. MacGowan, C. Perry, N. Moorjani, 2008 .

In vitro pharmacodynamics of omadacycline against Escherichia coli and Acinetobacter baumannii.

K. Bowker, A. MacGowan, A. Noel, 2020, The Journal of antimicrobial chemotherapy.

Colistin susceptibility testing: time for a review.

K. Bowker, A. MacGowan, A. Noel, 2014, The Journal of antimicrobial chemotherapy.

Tigecycline pharmacokinetic/pharmacodynamic update.

A. MacGowan, A. Macgowan, 2008, The Journal of antimicrobial chemotherapy.

Challenges in the bioanalysis of tetracyclines: Epimerisation and chelation with metals.

A. MacGowan, S. Grier, M. Bayliss, 2019, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

In-vitro synergy testing of nine antimicrobial combinations against Listeria monocytogenes.

A. MacGowan, D. Reeves, H. Holt, 1990, The Journal of antimicrobial chemotherapy.

Frontline antibiotic therapy.

A. MacGowan, M. Albur, A. Macgowan, 2013, Clinical medicine.

Antimicrobial resistance surveillance in urinary tract infections in primary care.

C. Mcnulty, A. MacGowan, Charles R Beck, 2016, The Journal of antimicrobial chemotherapy.

Problems of basing patient recruitment for primary care studies on routine laboratory submissions

C. Mcnulty, A. MacGowan, A. Lovering, 2007, Journal of Clinical Pathology.

Listeriosis--the therapeutic options.

A. MacGowan, A. Macgowan, 1990, The Journal of antimicrobial chemotherapy.

Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire.

A P MacGowan, A H Thomson, J F Wilson, 2002, The Journal of antimicrobial chemotherapy.

Cefuroxime resistance in non-beta-lactamase Haemophilus influenzae is linked to mutations in ftsI.

A. MacGowan, P. Bennett, M. Wootton, 2003, The Journal of antimicrobial chemotherapy.

Original articles Cefuroxime resistance in non-β-lactamase Haemophilus influenzae is linked to mutations in ftsI

A. MacGowan, P. Bennett, M. Wootton, 2003 .

The pharmacokinetics of intravenous ciprofloxacin 400 mg 12 hourly in patients with severe sepsis: the effect of renal function and intra-abdominal disease.

A. MacGowan, A. Hedges, D. Reeves, 1997, The Journal of antimicrobial chemotherapy.

Use of a clinical Escherichia coli isolate expressing lux genes to study the antimicrobial pharmacodynamics of moxifloxacin.

K. Bowker, A. MacGowan, H. Wiesinger-Mayr, 1999, The Journal of antimicrobial chemotherapy.

Activity of AZD2563, a Novel Oxazolidinone, against Staphylococcus aureus Strains with Reduced Susceptibility to Vancomycin or Linezolid

K. Bowker, A. MacGowan, R. Howe, 2003, Antimicrobial Agents and Chemotherapy.

Vancomycin-resistant Staphylococcus aureus

K. Bowker, T. Feest, A. MacGowan, 1998, The Lancet.

Enzyme kinetics and biochemical analysis of ImiS, the metallo-beta-lactamase from Aeromonas sobria 163a.

S. Gamblin, A. MacGowan, P. Bennett, 1996, The Journal of antimicrobial chemotherapy.

[Endemic heteroresistant glycopeptide intermediate Staphylcoccus aureus (hGISA) comprising unrelated clonal types and not associated with vancomycin therapy].

A. MacGowan, T. Walsh, M. Jones, 2002, Pathologie-biologie.

BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials.

K. Bowker, A. MacGowan, M. Wootton, 2002, The Journal of antimicrobial chemotherapy.

Antimicrobial Activity of Moxifloxacin and Levofloxacin Photodegradation Products

A. MacGowan, J. Sunderland, C. Tobin, 1999, Drugs.

The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria.

K. Bowker, A. MacGowan, M. Wootton, 1996, Journal of Antimicrobial Chemotherapy.

In Vitro Activities of Y-688, a New 7-Substituted Fluoroquinolone, against Anaerobic Bacteria

K. Bowker, A. MacGowan, M. Wootton, 1998, Antimicrobial Agents and Chemotherapy.

Once-daily aminoglycoside dosing

David E. Reeves, A. MacGowan, J. Aguado, 1993, The Lancet.

The passage of bacteria through surgical drapes.

A. Blom, K. Bowker, C. Estela, 2000, Annals of the Royal College of Surgeons of England.

Treatment of Gram-positive bone and joint infection: authors' response

A. MacGowan, E. Darley, 2004 .

Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2

A. MacGowan, S. Grier, A. Noel, 2020, Journal of Global Antimicrobial Resistance.

A reverse-phase, isocratic high-performance liquid chromatography assay for levofloxacin.

A. MacGowan, J. Sunderland, L. White, 1999, The Journal of antimicrobial chemotherapy.

Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.

K. Bowker, A. MacGowan, M. Avison, 2019, The Journal of antimicrobial chemotherapy.

Characterisation of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-2018

K. Bowker, A. MacGowan, M. Avison, 2019, bioRxiv.

Development of a novel assay method for colistin sulphomethate.

A. MacGowan, M. Wootton, H. Holt, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Detection of glycopeptide resistance in Staphylococcus aureus.

A. MacGowan, P. Bennett, R. Howe, 2001, The Journal of antimicrobial chemotherapy.

Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy.

A. MacGowan, M. Potter, D. Reeves, 1990, The Journal of antimicrobial chemotherapy.

MICROBIOLOGY OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN GREECE: A PROPOSED CLINICAL PREDICTION SCORE FOR THE CAUSATIVE PATHOGEN.

A. MacGowan, Eirini Christaki, E. Giamarellos‐Bourboulis, 2019, International journal of antimicrobial agents.

Pharmacodynamics of the Antibacterial Effect and Emergence of Resistance to Tomopenem, Formerly RO4908463/CS-023, in an In Vitro Pharmacokinetic Model of Staphylococcus aureus Infection

K. Bowker, A. MacGowan, A. Noel, 2008, Antimicrobial Agents and Chemotherapy.

Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics.

A. MacGowan, 2011, Current opinion in pharmacology (Print).

Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and G.

K. Bowker, A. MacGowan, M. Wootton, 1999, The Journal of antimicrobial chemotherapy.

Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations.

K. Bowker, A. MacGowan, D. Reeves, 1996, The Journal of antimicrobial chemotherapy.

Cefuroxime resistance in Haemophilus influenzae

A. MacGowan, D. Reeves, S. McCulloch, 1992, The Lancet.

Vancomycin efficacy (MIC and Bactericidality) in Clinical Outcome in Patients with Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteraemia

K. Bowker, A. MacGowan, A. Lovering, 2008 .

Practical guide: Patient and public involvement in antimicrobial medicines development research

Alasdair P. MacGowan, Andy Gibson, Michele Kok, 2018 .

Difficulties in the assay of liposomal amikacin (MiKasome) in serum.

A. MacGowan, A. Lovering, L. White, 1999, The Journal of antimicrobial chemotherapy.

Choosing the right anticoagulant: a critical choice when assessing pharmacokinetic parameters for tetracyclines obtained from human blood samples.

A. MacGowan, S. Grier, A. Lovering, 2019, The Journal of antimicrobial chemotherapy.

Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections

C. Tebé, L. Leibovici, A. MacGowan, 2018, Antimicrobial Resistance & Infection Control.

Assay of serum teicoplanin concentrations in clinical specimens: a comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay.

A. MacGowan, D. Reeves, A. Lovering, 1994, The Journal of antimicrobial chemotherapy.

Listerious—the therapeutic options

A. MacGowan, A. Macgowan, 1990 .

The effect of duration of therapy for treatment of Staphylococcus aureus blood stream infection: an application of cloning to deal with immortal-time bias in an analysis of data from a cohort study (BSI-FOO)

A. MacGowan, C. Rogers, Rebecca N. Evans, 2022, The Journal of antimicrobial chemotherapy.

Comment on: The case for 'conservative pharmacotherapy'.

A. MacGowan, A. Noel, M. Albur, 2021, The Journal of antimicrobial chemotherapy.

Use of Intravenous Co-Trimoxazole to Treat Bacterial Infection: Analysis of 50 Treatment Episodes

A. MacGowan, E. Barton, 2010, Journal of chemotherapy.

Early warning score: a dynamic marker of severity and prognosis in patients with Gram-negative bacteraemia and sepsis

A. MacGowan, F. Hamilton, M. Albur, 2016, Annals of Clinical Microbiology and Antimicrobials.

The value of MALDI-TOF failure to provide an identification of Staphylococcal species direct from blood cultures and rule out Staphylococcus aureus bacteraemia: a post-hoc analysis of the RAPIDO trial

A. MacGowan, F. Hamilton, Rebecca N. Evans, 2020, Access Microbiology.

Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study.

A. Oliver, L. Leibovici, D. Paterson, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics of once-a-day netilmicin (6 mg/kg) in neonates.

A. MacGowan, D. Reeves, A. Lovering, 1996, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers.

A. MacGowan, D. Reeves, R. Wise, 1989, The Journal of antimicrobial chemotherapy.

HPLC assay of cefixime in serum and CSF.

A. MacGowan, D. Reeves, A. Lovering, 1993, The Journal of antimicrobial chemotherapy.

Pharmacodynamics of inhaled amikacin (BAY 41-6551) studied in an in vitro pharmacokinetic model of infection

K. Bowker, A. MacGowan, A. Noel, 2018, Journal of Antimicrobial Chemotherapy.

Cefuroxime axetil in the sick elderly patient.

H. Humphreys, A. MacGowan, C. Case, 1992, The Journal of antimicrobial chemotherapy.

The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill.

M. Singer, A. MacGowan, T. Whitehouse, 2002 .

An HPLC assay for daptomycin in serum.

A. MacGowan, A. Lovering, C. Tobin, 2008, The Journal of antimicrobial chemotherapy.